POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER
Clinical trials for POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER trials appear
Sign up with your email to follow new studies for POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New chemo dosing shows promise for kids with rare cancers
⭐️ CURE ⭐️ CompletedThis study tested a new way of giving chemotherapy (called dose-adjusted EPOCH-R) to children with certain B-cell cancers, including lymphoma and post-transplant disorders. The goal was to see if this approach, which worked well in adults, could improve cure rates while causing f…
Matched conditions: POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER
Phase: EARLY_PHASE1 • Sponsor: Baylor College of Medicine • Aim: ⭐️ CURE ⭐️
Last updated Jun 10, 2026 13:29 UTC
-
Can a simple virus test save transplant patients from cancer?
Knowledge-focused CompletedThis study followed 509 kidney transplant recipients to see if monitoring Epstein-Barr virus (EBV) levels in blood could help predict serious infections, a type of cancer called PTLD, or death. Participants had regular blood tests for EBV after their transplant. The goal was to f…
Matched conditions: POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER
Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:01 UTC